Sodium Sources and Sodium Intake in a Representative Sample of Spanish Children
Launched by UNIVERSIDAD COMPLUTENSE DE MADRID · Mar 13, 2018
Trial Information
Current as of August 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Specific Aims
1. To stablish the average sodium intake in Spanish children, using a 24-h urine sample and validated dietary questionnaires.
2. To compare 24-hour urinary sodium measurement to the dietary survey method
3. To study the relationship between sodium intake and blood pressure levels in Spanish scholars.
4. To analyze the relationship between sodium intake and overweight/obesity in Spanish children using anthropometric and bioimpedance analysis measures.
5. To identify main food sources of sodium in the diet of Spanish schoolchildren and the use of discretionary salt.
6. Provide ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 7 and 11 years old
- Exclusion Criteria:
- • Those who have any clinical problem, which may modify the results of the analysis: metabolic or chronic diseases (liver, kidney, diabetes, hypothesis or hyperkalemia), pharmacological treatment during the 3 months prior to the study with corticosteroids, insulin, diuretics or other drugs that may modify blood pressure figures, surgery or serious infectious diseases in the previous 6 months.
- • Those who were not in the school when the measures were taken.
About Universidad Complutense De Madrid
The Universidad Complutense de Madrid (UCM) is a prestigious academic institution renowned for its commitment to research and innovation in various fields, including health sciences. As a prominent sponsor of clinical trials, UCM leverages its extensive resources and expertise to advance medical knowledge and improve patient outcomes. The university fosters collaboration among researchers, clinicians, and industry partners, ensuring the highest standards of ethics and scientific rigor in its clinical research initiatives. UCM's dedication to education and research excellence positions it as a leader in the development of new therapeutic interventions and health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Trial Officials
Rosa M Ortega Anta, Full Prof.
Principal Investigator
Universidad Complutense de Madrid
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials